Chimeric antibodies for the treatment of hematologic malignancy.
Dyer
M J
MJ
Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, England.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000032:analysis* / Q000276:immunology; D000951:Antigens, Neoplasm; D000074301:CD52 Antigen; D006023:Glycoproteins; D006801:Humans; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D008223:Lymphoma / Q000276:immunology / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D000074301:CD52 Antigen; C000613862:CD52 protein, human; D006023:Glycoproteins; D011993:Recombinant Fusion Proteins